The EU drug markets report provides the first comprehensive overview of illicit drug markets in the European Union. The report combines Europol’s strategic perspective and operational understanding of trends and developments in organised crime with the EMCDDA’s ongoing monitoring and analysis of various aspects of the drug phenomenon in Europe and beyond. The EU drug market is complex, and the analysis provided here spans numerous topics such as production, consumer markets, trafficking, organised crime and policy responses. Taking a multi-source approach, the report reviews the markets for... heroin, cocaine, cannabis, amphetamine, methamphetamine, ecstasy and new psychoactive substances. It also provides concrete action points for the areas where the current EU response to the drug market and its consequent harms may be improved. This publication is an essential reference for law enforcement professionals, policymakers, the academic community and indeed for anyone seeking up-to-date information and analysis on drug markets in Europe.